Colorectal Cancer Clinical Trials in Maryland

Showing 161-180 of 180 trials

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

NCT00756977

This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.

Colon Cancer

Braintree Laboratories394 participantsStarted Aug 2008

Mobile, Alabama, United States • Jupiter, Florida, United States • Miami, Florida, United States +9 more locations

COMPLETEDNA17 miles

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

NCT00087360

RATIONALE: Evaluating the knowledge and attitudes of healthy participants toward a new diet and gene test for colorectal cancer risk may help doctors improve acceptance of colorectal cancer screening. PURPOSE: This clinical trial is studying the knowledge and attitudes of healthy participants toward genetic and environmental risk assessment for colorectal cancer.

Colorectal Cancer

Fox Chase Cancer CenterStarted Nov 2003

Bethesda, Maryland, United States • Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States +1 more locations

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

Colorectal Cancer Trials in Other Cities

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Study of XL281 in Adults With Solid Tumors

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Other Conditions in Maryland